ROCHESTER, Mich. , June 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering of 1,538,500 shares of its common stock,
ROCHESTER, Mich. , June 04, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering of shares of its common stock. In connection with the offering,
ROCHESTER, Mich. , May 31, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in two investor conferences being held in June. Event: William Blair & Company 39 th Annual Growth
ROCHESTER, Mich. , May 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019 . Quarterly comparisons are to the same year-ago quarter.
Combined offering integrates EHR network and proactive patient services to improve access and adherence LAS VEGAS , April 30, 2019 /PRNewswire/ -- EVERSANA ™, the leading independent provider of global services to the life science industry, and OptimizeRx Corp.
Stephen Silvestro Brings more than 20 Years’ Experience in Direct Operations, Sales, and Partner Network Growth, to Lead Revenue Activities and Strengthen the Go-to-Market ROCHESTER, Mich. , April 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health
ROCHESTER, Mich. , April 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Wednesday, May 8, 2019 at 4:30 p.m. Eastern time to discuss results for the first quarter ended March
ROCHESTER, Mich. , April 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at three institutional investor conferences in May. Event: Oppenheimer Emerging Growth Conference Date: May
Company’s Platform is Technically Integrated with Epic and Cerner, and New Hospital Sales Executive Will Focus on Health System Partnerships ROCHESTER, Mich. , April 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical
More than 600 providers polled, showing awareness of patients’ increasing drug costs but missed opportunity to support patient financial savings ROCHESTER, Mich. , March 20, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical